Close

Furiex Pharmaceuticals (FURX) Price Target Raised to $137 at Ladenburg Thalmann

February 4, 2014 1:06 PM EST Send to a Friend
Ladenburg Thalmann maintained a Buy rating on Furiex Pharmaceuticals (NASDAQ: FURX) and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login